Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women of age 14-45 years
- • \>1 year post-menarche with moderate acne vulgaris who have no known contraindications to combined oral contraceptives
- • Otherwise healthy, except for the presence of moderate acne
- • Smokers up to a maximum age of 30 (inclusive) at inclusion
- Exclusion Criteria:
- • Pregnancy, lactation (less than three menstrual cycles since delivery, abortion, or lactation before start of treatment)
- • Obesity (Body Mass Index \> 30 kg/m2)
- • Hypersensitivity to any ingredient of the study drug
- • Any disease or condition that may worsen under hormonal treatment
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Chengdu, Sichuan, China
Changsha, Hunan, China
Guangzhou, Guangdong, China
Nanjing, Jiangsu, China
Shanghai, , China
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials